Loading clinical trials...
Loading clinical trials...
Rheumatoid and psoriatic arthritis patients benefit from anti-TNF-α therapy, once it is effective in reducing joint and skin manifestations in 60-70% of patients with inflammatory articular joint and ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universidade Federal do Rio de Janeiro
NCT07171983 · Rheumatoid Arthritis
NCT07569848 · Arthrosis, Ankle Arthritis, and more
NCT05869955 · Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathy, and more
NCT07558850 · Rheumatoid Arthritis, Dermatomyositis, and more
NCT07486960 · Psoriatic Arthritis
Hospital Universitário Clementino Fraga Filho
Rio de Janeiro, Rio de Janeiro
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions